Jane Street’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Jane Street's ABUS Position: Q3 2026 in Review
Jane Street opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 571,080 shares worth $2.73M. The stake represents ﹤0.01% of the portfolio and ranks #4635 among its holdings. This is a return to the name: Jane Street previously reported a position in ABUS as recently as Q4 2025.
Jane Street first reported a position in ABUS in Q1 2014 and has held it in 28 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Jane Street held 571,080 shares of Arbutus Biopharma worth $2.73M as of Q3 2026.
- Arbutus Biopharma was a new Jane Street position in Q3 2026.
- Arbutus Biopharma made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #4635 holding.
- Jane Street first reported a position in Arbutus Biopharma in Q1 2014 and has held it in 28 quarters since.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.